AstraZeneca (AZN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Sachin Jain from Bank ...

SAN DIEGO, CA / ACCESSWIRE / January 9, 2025 / Robbins LLP reminds investors that a class action was filed on behalf of all ...

Alzhemier’s disease could be diagnosed up to a decade earlier after the world’s biggest study of proteins is completed. The ...

Daiichi Sankyo's stock dropped 25% due to disappointing clinical data, but upcoming studies could drive a rebound for ...

Shares of AstraZeneca PLC AZN rose 2.18% to £109.88 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.83% to 8,319.69.

A new weight loss biotech launched with $410 million and three assets from China. Roche's Chugai penned a deal to develop ...

A two-drug combination extended OS compared with standard first-line osimertinib for certain patients with advanced lung ...

A world leading UK Biobank study of half a million Brits could unlock the mysteries of ‘proteomics’ to prevent and cure ...

New treatments like dotinurad provide safer, more effective solutions for millions battling gout and hyperuricemia.

The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing ...

Recently, an 80-year-old man in Ahmedabad tested positive for human metapneumovirus (hMPV), adding to the growing cases of ...